Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 2
1971 1
1981 1
1983 4
1984 2
1985 2
1986 1
1987 3
1988 2
1989 2
1990 1
1991 1
1992 4
1993 4
1994 1
1995 1
1996 3
1997 1
1998 2
1999 2
2000 2
2001 2
2002 1
2003 4
2004 7
2005 5
2006 4
2007 3
2008 1
2009 3
2010 4
2011 5
2012 4
2013 11
2014 13
2015 13
2016 13
2017 13
2018 5
2019 7
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

150 results
Results by year
Filters applied: . Clear all
Page 1
Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study.
Nakagawa Y, Mukai S, Yamada S, Matsuoka M, Tarumi E, Hashimoto T, Tamura C, Imaizumi A, Nishihira J, Nakamura T. Nakagawa Y, et al. Among authors: imaizumi a. J Orthop Sci. 2014 Nov;19(6):933-9. doi: 10.1007/s00776-014-0633-0. Epub 2014 Oct 13. J Orthop Sci. 2014. PMID: 25308211 Free PMC article. Clinical Trial.
Innovative preparation of curcumin for improved oral bioavailability.
Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T. Sasaki H, et al. Among authors: imaizumi a. Biol Pharm Bull. 2011;34(5):660-5. doi: 10.1248/bpb.34.660. Biol Pharm Bull. 2011. PMID: 21532153 Free article. Clinical Trial.
A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients.
Kanai M, Otsuka Y, Otsuka K, Sato M, Nishimura T, Mori Y, Kawaguchi M, Hatano E, Kodama Y, Matsumoto S, Murakami Y, Imaizumi A, Chiba T, Nishihira J, Shibata H. Kanai M, et al. Among authors: imaizumi a. Cancer Chemother Pharmacol. 2013 Jun;71(6):1521-30. doi: 10.1007/s00280-013-2151-8. Epub 2013 Mar 30. Cancer Chemother Pharmacol. 2013. PMID: 23543271 Free article. Clinical Trial.
Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD.
Funamoto M, Sunagawa Y, Katanasaka Y, Miyazaki Y, Imaizumi A, Kakeya H, Yamakage H, Satoh-Asahara N, Komiyama M, Wada H, Hasegawa K, Morimoto T. Funamoto M, et al. Among authors: imaizumi a. Int J Chron Obstruct Pulmon Dis. 2016 Aug 26;11:2029-34. doi: 10.2147/COPD.S104490. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27616885 Free PMC article. Clinical Trial.
Preventive effect of curcumin and its highly bioavailable preparation on hearing loss induced by single or repeated exposure to noise: A comparative and mechanistic study.
Yamaguchi T, Yoneyama M, Onaka Y, Imaizumi A, Ogita K. Yamaguchi T, et al. Among authors: imaizumi a. J Pharmacol Sci. 2017 Aug;134(4):225-233. doi: 10.1016/j.jphs.2017.07.003. Epub 2017 Aug 8. J Pharmacol Sci. 2017. PMID: 28826625 Free article.
PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitor.
Fujimura A, Nakayama K, Imaizumi A, Kawamoto M, Oyama Y, Ichimiya S, Umebayashi M, Koya N, Morisaki T, Nakagawa T, Onishi H. Fujimura A, et al. Among authors: imaizumi a. Cancer Immunol Immunother. 2019 Oct;68(10):1649-1660. doi: 10.1007/s00262-019-02403-y. Epub 2019 Sep 27. Cancer Immunol Immunother. 2019. PMID: 31562536
Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover study.
Sunagawa Y, Hirano S, Katanasaka Y, Miyazaki Y, Funamoto M, Okamura N, Hojo Y, Suzuki H, Doi O, Yokoji T, Morimoto E, Takashi T, Ozawa H, Imaizumi A, Ueno M, Kakeya H, Shimatsu A, Wada H, Hasegawa K, Morimoto T. Sunagawa Y, et al. Among authors: imaizumi a. J Nutr Sci Vitaminol (Tokyo). 2015;61(1):37-44. doi: 10.3177/jnsv.61.37. J Nutr Sci Vitaminol (Tokyo). 2015. PMID: 25994138 Free article. Clinical Trial.
Tissue amino acid profiles are characteristic of tumor type, malignant phenotype, and tumor progression in pancreatic tumors.
Hiraoka N, Toue S, Okamoto C, Kikuchi S, Ino Y, Yamazaki-Itoh R, Esaki M, Nara S, Kishi Y, Imaizumi A, Ono N, Shimada K. Hiraoka N, et al. Among authors: imaizumi a. Sci Rep. 2019 Jul 8;9(1):9816. doi: 10.1038/s41598-019-46404-4. Sci Rep. 2019. PMID: 31285536 Free PMC article.
Attenuation of indirect markers of eccentric exercise-induced muscle damage by curcumin.
Tanabe Y, Maeda S, Akazawa N, Zempo-Miyaki A, Choi Y, Ra SG, Imaizumi A, Otsuka Y, Nosaka K. Tanabe Y, et al. Among authors: imaizumi a. Eur J Appl Physiol. 2015 Sep;115(9):1949-57. doi: 10.1007/s00421-015-3170-4. Epub 2015 Apr 29. Eur J Appl Physiol. 2015. PMID: 25921600 Free PMC article. Clinical Trial.
RBPJ and MAML3: Potential Therapeutic Targets for Small Cell Lung Cancer.
Onishi H, Ichimiya S, Yanai K, Umebayashi M, Nakamura K, Yamasaki A, Imaizumi A, Nagai S, Murahashi M, Ogata H, Morisaki T. Onishi H, et al. Among authors: imaizumi a. Anticancer Res. 2018 Aug;38(8):4543-4547. doi: 10.21873/anticanres.12758. Anticancer Res. 2018. PMID: 30061220
150 results
Jump to page
Feedback